ISRCTN52897947已完成未知
A randomised, multicentre, open label trial comparing the start of the induction of labour with intravenous oxytocin according to the circadian rhythm with standard care
Academic Medical Centre (AMC) (Netherlands)0 个研究点目标入组 371 人开始时间: 2005年12月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 371
研究概览
简要总结
2009 Results article in https://pubmed.ncbi.nlm.nih.gov/19250367/ (added 15/07/2021)
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Female
入选标准
- •Women are eligible to participate when the clinician judges that it is favourable to induce labour and the cervix is favourable for induction with a drip of oxytocin.
排除标准
- •1. Intrauterine foetal death
- •2. Maternal age below 18 years
- •3. Insufficient understanding of the meaning of the trial
- •4. Language problems
- •5. Contraindication for amniotomy
- •6. Secondary caesarean section in the medical history
- •7. Gestational age shorter than 36 weeks
- •8. Necessity for timed or immediate intervention because of suspected foetal distress
研究者
相似试验
已完成
不适用
A randomized, multicentre, open label trial comparing the start of the induction of labor with intravenous oxytocin according to the circadian rhythm with standard care.Induction of labor with intravenous oxytocin.NL-OMON22012AMC:J.J.H. Bakker, Dr.J.A.M. van der Post, Dr.R. de Vos.OLVG: Dr.J.M.M.van LithSLVZ:Drs.A.J.van Veelen400
已完成
不适用
An open label, randomised multicentre comparative trial of five years adjuvant exemestane treatment versus adjuvant tamoxifen followed by exemestane in postmenopausal women with early breast cancerCancerBreast cancerISRCTN75225940The University of Birmingham (UK)1,275
已完成
2 期
A randomised open-labelled multicentre trial of the efficacy of epirubicin, oxaliplatin and capecitabine (EOX) with or without panitumumab in previously untreated advanced oesophago-gastric cancerAdvanced oesophago-gastric cancerOesophago-gastric cancerCancerISRCTN65080435The Royal Marsden Hospital NHS Foundation Trust (UK)553
已完成
2 期
Bendamustine, thalidomide, dexamethasone dose escalation study in relapsed/refractory myelomaMultiple myelomaCancerISRCTN90889843niversity of Leeds (UK)94
已完成
3 期
A randomised multicentre clinical phase IIIb trial for patients suffering from pancreatic adenocarcinoma receiving defined second or higher line chemotherapy and additionally parenteral nutrition (study arm A) or best supportive nutritional care (study arm B)Advanced pancreatic adenocarcinomaMalignant neoplasm of pancreasCancerISRCTN60516908niversity of Heidelberg (Germany)120